Dasatinib monohydrate is a selective tyrosine kinase receptor inhibitor.

Dovitinib Lactate is lactate salt of Dovitinib with potential antineoplastic activity.

Dasatinib is a pyrimidine and thiazole derived antineoplastic agent and protein kinase inhibitor of BCR-ABL kinase.

Nilotinib is an orally bioavailable aminopyrimidine-derivative Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.

Dovitinib is a benzimidazole-quinolinone compound and receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity.

GSK2256098 is a potent, selective, reversible, and ATP competitive FAK kinase inhibitor.

NSC228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.

AZD3759 is a potent, oral active, CNS-penetrant EGFR inhibitor.